Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma | Citedby Results | Oncology Research and Treatment | Karger Publishers

Skip to Main Content

Skip Nav Destination

Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma

Oncol Res Treat (2020) 43 (6): 264–275.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Enantiomeric C-6 fluorinated swainsonine derivatives as highly selective and potent inhibitors of α-mannosidase and α-l-rhamnosidase: Design, synthesis and structure-activity relationship study

Feng-Teng Gao
Ming Zhang
Yuna Shimadate
Atsushi Kato
Yi-Xian Li
Yue-Mei Jia
Chu-Yi Yu

European Journal of Medicinal Chemistry (2025) 282: 117031.

Golgi α-mannosidase: opposing structures of Drosophila melanogaster and novel human model using molecular dynamics simulations and docking at different pHs

Artem Drogalin
Luís S. Monteiro
Maria José Alves
Tarsila G. Castro

Journal of Biomolecular Structure and Dynamics (2024) 42 (5): 2714.

Glycosidase-targeting small molecules for biological and therapeutic applications

Yujun Kim
Hui Li
Joohee Choi
Jihyeon Boo
Hyemi Jo
Ji Young Hyun
Injae Shin

Chemical Society Reviews (2023) 52 (20): 7036.

Glycosidase activated prodrugs for targeted cancer therapy

Harlei Martin
Laura Ramírez Lázaro
Thorfinnur Gunnlaugsson
Eoin M. Scanlan

Chemical Society Reviews (2022) 51 (23): 9694.